Prolira Deltascan Brain state monitoring to detect acute encephalopathy

Detecting acute encephalopathy and delirium in hospitalized patients is extremely challenging. Traditional screening methods, such as questionnaires, miss over 80% of delirium cases, leading to delayed diagnosis and treatment. This underdiagnosis can result in worse patient outcomes, longer hospital stays, and increased healthcare costs.

DeltaScan by Prolira is designed to objectively detect acute encephalopathy and delirium at the bedside. Using high-impedance electrodes and advanced analog signal conditioning, DeltaScan provides reliable, real-time brain function monitoring. This enables clinicians to identify at-risk patients much earlier than with traditional methods, improving patient outcomes, reducing hospital stays, and lowering overall healthcare costs.